The key difference
Phentermine is a sympathomimetic amine (stimulant) that increases norepinephrine to suppress appetite directly. It works fast — most patients notice reduced hunger within the first few days. But it’s FDA-approved only for short-term use (up to 12 weeks) and is a Schedule IV controlled substance.
Contrave combines naltrexone (opioid antagonist) with bupropion (NDRI antidepressant). Rather than suppressing appetite through stimulation, it targets the brain’s reward system — reducing the psychological pull of food, cravings, and emotional eating patterns. It’s approved for long-term use.
“Phentermine turns down the hunger signal. Contrave turns down the reward signal. Same goal, fundamentally different approach.”
Side-by-side comparison
| Feature | Phentermine | Contrave |
|---|---|---|
| Drug class | Sympathomimetic amine (stimulant) | Naltrexone/bupropion (opioid antagonist + NDRI) |
| Active ingredient | Phentermine HCl | Naltrexone 8mg / Bupropion 90mg |
| How taken | Oral tablet, once daily (morning) | Oral tablet, twice daily |
| FDA approved | 1959 | September 2014 |
| Avg weight loss | 5–10% body weight (12 weeks) | 5–8% body weight (56 weeks) |
| Duration of use | Short-term (up to 12 weeks) | Long-term (chronic) |
| DEA schedule | Schedule IV controlled substance | Not controlled |
| Onset of action | Days (rapid) | 4–8 weeks (gradual) |
| Insurance coverage | Widely covered; very inexpensive | Good coverage; generic available |
| Typical cost | low monthly generic pricing | moderate monthly out-of-pocket pricing |
| Main side effects | Insomnia, dry mouth, elevated HR, restlessness | Nausea, constipation, headache, insomnia |
| Warnings | Cardiovascular monitoring required | Black box warning (suicidality), seizure risk |
| Best for | Quick-start appetite suppression, short-term goals | Emotional eaters, cravings-driven weight gain, long-term use |
When phentermine may be the right choice
- You need fast-acting appetite suppression
- You have a short-term weight loss goal (event, surgery prep, step therapy bridge)
- Cost is a primary concern (low monthly generic pricing)
- You don’t have cardiovascular contraindications
- You want to start losing weight quickly while exploring long-term options
Phentermine’s strength is speed and simplicity. It’s the fastest-acting FDA-approved weight loss medication, and at low monthly generic pricing for generics, it’s the most affordable. The tradeoff is the 12-week limit — it’s a sprint, not a marathon. For patients who need immediate momentum or who are using it as a bridge to longer-term treatment, phentermine is often the right starting point.
When Contrave may be the right choice
- Your weight gain is driven by emotional eating or food cravings
- You need a long-term medication (not limited to 12 weeks)
- You have concurrent depression (bupropion has antidepressant properties)
- You’ve already completed a phentermine course and need ongoing treatment
- You want to address the psychological drivers of overeating
Contrave is often the right next step after phentermine, or the better first choice when the primary issue isn’t hunger but the reward response to food. For patients who describe “not being able to stop once they start eating” or who eat in response to stress, boredom, or emotion, Contrave’s naltrexone component directly targets that mechanism.
For a deeper look at what to expect when taking Contrave, including the titration process, read our Contrave side effects guide.
Using them sequentially
Phentermine and Contrave can complement each other over time as part of a planned treatment sequence. This is one of the most common medication progressions we see at PEAK:
- Phentermine first for rapid weight loss and step therapy documentation
- Transition to Contrave for long-term maintenance or if cravings are the primary issue
- Both can serve as step therapy before GLP-1 medications if needed
- PEAK manages transitions to ensure continuity and minimize gaps in treatment
At PEAK, we often see patients who start with phentermine for the initial momentum, then transition to Contrave or a GLP-1 for long-term management. This isn’t a sign of failure — it’s a planned treatment evolution. Each medication serves a purpose in the overall strategy, and sequencing them correctly is part of building a sustainable weight loss plan.
How we help you decide
PEAK prescribes both phentermine and Contrave. The choice depends on what’s driving your weight gain, your timeline, and your insurance situation.
For some patients, the answer is phentermine first, then Contrave. For others, Contrave is the right starting point. Your clinician evaluates eating patterns, health history, and goals to determine which medication — or which sequence — will produce the best outcome for you.
If one medication isn’t working as expected, we adjust. The goal isn’t to commit to a single medication forever — it’s to find the right treatment at the right time for where you are in your treatment.







